bioAffinity Technologies, Inc. (BIAF)
USD 0.51
(9.09%)
USD 0.51
(9.09%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.11 Million USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 160.18 Thousand USD | 199.6% |
| 2020 | 53.46 Thousand USD | 0.0% |
| 2019 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 22.76 Thousand USD | -1.18% |
| 2024 Q1 | 23.03 Thousand USD | 0.0% |
| 2023 Q4 | 1.11 Million USD | -9.58% |
| 2023 FY | 1.11 Million USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | 1.23 Million USD | 0.0% |
| 2022 Q2 | - USD | -100.0% |
| 2022 Q1 | 149.69 Thousand USD | -6.55% |
| 2022 FY | - USD | -100.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 Q4 | 160.18 Thousand USD | 125.27% |
| 2021 Q1 | - USD | -100.0% |
| 2021 Q3 | 71.1 Thousand USD | 0.0% |
| 2021 FY | 160.18 Thousand USD | 199.6% |
| 2020 FY | 53.46 Thousand USD | 0.0% |
| 2020 Q4 | 53.46 Thousand USD | 0.0% |
| 2019 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aclaris Therapeutics, Inc. | 3.07 Million USD | 63.615% |
| Applied DNA Sciences, Inc. | 739.16 Thousand USD | -51.316% |
| Aspira Women's Health Inc. | 1.43 Million USD | 21.785% |
| Biodesix, Inc. | 35.22 Million USD | 96.825% |
| BioNexus Gene Lab Corp. | 98.76 Thousand USD | -1032.477% |
| bioAffinity Technologies, Inc. | 1.11 Million USD | 0.0% |
| Bionano Genomics, Inc. | 7.17 Million USD | 84.412% |
| CareDx, Inc | 28.27 Million USD | 96.045% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Castle Biosciences, Inc. | 14.19 Million USD | 92.122% |
| DarioHealth Corp. | 24.59 Million USD | 95.452% |
| Exact Sciences Corporation | 2.47 Billion USD | 99.955% |
| Fulgent Genetics, Inc. | 10.11 Million USD | 88.938% |
| Guardant Health, Inc. | 1.13 Billion USD | 99.902% |
| ICON Public Limited Company | 3.66 Billion USD | 99.969% |
| IDEXX Laboratories, Inc. | 622.88 Million USD | 99.82% |
| Illumina, Inc. | 1.48 Billion USD | 99.925% |
| Intelligent Bio Solutions Inc. | 81.32 Thousand USD | -1275.323% |
| iSpecimen Inc. | 29.13 Thousand USD | -3739.574% |
| Standard BioTools Inc. | 3.98 Million USD | 71.919% |
| MDxHealth SA | 35.56 Million USD | 96.855% |
| 23andMe Holding Co. | 67.84 Million USD | 98.351% |
| Medpace Holdings, Inc. | 142.12 Million USD | 99.213% |
| Myriad Genetics, Inc. | 130.9 Million USD | 99.146% |
| Mainz Biomed B.V. | 2.19 Million USD | 49.065% |
| ENDRA Life Sciences Inc. | 192.06 Thousand USD | -482.347% |
| NeoGenomics, Inc. | 606.06 Million USD | 99.815% |
| Neogen Corporation | 888.39 Million USD | 99.874% |
| Inotiv, Inc. | 399.4 Million USD | 99.72% |
| Natera, Inc. | 282.94 Million USD | 99.605% |
| OpGen, Inc. | 2.02 Million USD | 44.675% |
| OPKO Health, Inc. | 222.03 Million USD | 99.496% |
| Psychemedics Corporation | 945 Thousand USD | -18.356% |
| Prenetics Global Limited | 867.21 Thousand USD | -28.972% |
| Prenetics Global Limited | 867.21 Thousand USD | -28.972% |
| Precipio, Inc. | 106 Thousand USD | -955.158% |
| Personalis, Inc. | 1.23 Million USD | 9.362% |
| RadNet, Inc. | 812.06 Million USD | 99.862% |
| Sera Prognostics, Inc. | 840 Thousand USD | -33.151% |
| Sotera Health Company | 2.22 Billion USD | 99.95% |
| Neuronetics, Inc. | 59.28 Million USD | 98.113% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 2.317% |
| Star Equity Holdings, Inc. | 1.14 Million USD | 2.317% |
| Trinity Biotech plc | 54.65 Million USD | 97.953% |
| T2 Biosystems, Inc. | 6.59 Million USD | 83.048% |
| Twist Bioscience Corporation | 79.17 Million USD | 98.587% |
| Exagen Inc. | 19.23 Million USD | 94.184% |